Table 1

Baseline characteristics of study population according to SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery trial (SYNTAX) Scores

VariablesSYNTAX group 1 (n:169)SYNTAX group 2
(n:156)
P value
Age (years)60.2±11.763.5±10.30.006
Gender (n, %) (male)97, %57.476, %48.70.12
DM (n, %)56, %33.186, %55.10.001
HT (n, %)77, %45.681, %51.90.025
HL (n, %)43, %25.460, %38.50.001
Systolic blood pressure (mm Hg)134.1±23.2134.3±19.30.96
Diastolic blood pressure (mm Hg)75.2±13.174.2±12.20.46
Heart rate (beat/min)73.5±16.777.3±16.30.04
Smoking (n, %)74, %43.884, %53.80.07
Glucose (mg/dL)121.5±53.9134.9±54.60.03
CR (mg/dL)0.88±0.270.89±0.340.92
Ure (mg/dL)36.6±14.639.9±19.60.08
Total cholestrol (mg/dL)189.9±43.8194.9±52.70.34
Trigliseride (mg/dL)153.3±87.06132.5±870.55
LDL (mg/dL)119.1±38.3122.2±42.80.49
White blood cell8.41±3.138.57±2.360.63
Haemoglobin (g/dL)13.3±1.7612.5±1.10.001
Platelet246.8±94.6260.3±92.60.24
EF %56.0±6.755.3±6.80.35
Height (cm)168.3±7.9164.6±8.80.001
Weight (kg)81.7±14.381.5±13.70.91
Waist (cm)97.0±12.098.8±13.20.19
Hip (cm)96.2±12.7101.7±12.70.001
BMI29.1±5.430.1±5.10.09
BFP36.9±6.438.5±6.90.02
BFM30.9±9.232.0±9.30.32
RFM31.2±6.836.2±7.90.001
  • BFM, body fat mass; BFP, body fat percentage; BMI, body mass index; CR, creatinine; DM, diabetes mellitus; EF, ejection fraction; HL, hyperlipidaemia; HT, hypertension; LDL, low-density lipoprotein; RFM, relative fat mass.